| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-06 |
| mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-06 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-06 |
| mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-05 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |
| mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
| mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
5e-05 |
| mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
6e-05 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
7e-05 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
9e-05 |